PMID- 28537059
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220331
IS  - 2233-6079 (Print)
IS  - 2233-6087 (Electronic)
IS  - 2233-6079 (Linking)
VI  - 41
IP  - 3
DP  - 2017 Jun
TI  - The Effect of 12 Weeks Aerobic, Resistance, and Combined Exercises on Omentin-1 
      Levels and Insulin Resistance among Type 2 Diabetic Middle-Aged Women.
PG  - 205-212
LID - 10.4093/dmj.2017.41.3.205 [doi]
AB  - BACKGROUND: Recent studies have shown that omentin-1 derived from adipokines can 
      affect physiological regulations and some metabolic dis-eases such as type 2 
      diabetes mellitus (T2DM). METHODS: The purpose of this study was to examine the 
      impact of 12 weeks of aerobic (cycle ergometer), resistance, and combined 
      exercises on omentin-1 level, glucose and insulin resistance indices in 
      overweight middle age women with T2DM. In this study, 60 overweight middle age 
      diabetic women were selected using simple random sampling and they were assigned 
      to three groups of aerobic exercise (n=12), resistant exercise (n=12) and 
      combined exercise (n=13), and one control group (n=15). Exercises were done in a 
      three times per week sessions for a total of 12 weeks. Blood samples were 
      collected before each exercise session and 24 hours after of the last session. 
      RESULTS: Present study showed that fasting blood sugar decreased significantly in 
      all intervention groups, while homeostasis model assessment of insulin resistance 
      (HOMA-IR) decreased only in the aerobic and combined exercises groups. 
      Furthermore, there was a significant increase in the omentin-1 level only in the 
      combined exercise group. CONCLUSION: Compared to aerobic and resistance 
      exercises, 12 weeks of combined exercise was more efficient in improving HOMA-IR 
      and increasing serum omentin-1 among women with T2DM.
CI  - Copyright (c) 2017 Korean Diabetes Association
FAU - AminiLari, Zeinab
AU  - AminiLari Z
AD  - Department of Clinical Epidemiology and Biostatistics, McMaster University, 
      Hamilton, ON, Canada.
FAU - Fararouei, Mohammad
AU  - Fararouei M
AUID- ORCID: 0000-0001-9362-328X
AD  - Shiraz HIV/AIDS Research Center, Institute of Health, Shiraz University of 
      Medical Sciences, Shiraz, Iran. dianati.epid@gmail.com.
FAU - Amanat, Sasan
AU  - Amanat S
AD  - Department of Nutrition, Shiraz University of Medical Sciences School of 
      Nutrition and Food Sciences, Shiraz, Iran.
FAU - Sinaei, Ehsan
AU  - Sinaei E
AD  - Department of Physical Therapy, Shiraz University of Medical Sciences School of 
      Rehabilitation Sciences, Shiraz, Iran.
FAU - Dianatinasab, Safa
AU  - Dianatinasab S
AD  - Department of Nutrition, Shiraz University of Medical Sciences School of 
      Nutrition and Food Sciences, Shiraz, Iran.
FAU - AminiLari, Mahmood
AU  - AminiLari M
AD  - Department of Clinical Epidemiology and Biostatistics, McMaster University, 
      Hamilton, ON, Canada.
FAU - Daneshi, Nima
AU  - Daneshi N
AD  - Department of Epidemiology, Student Research Committee, Shiraz University of 
      Medical Sciences School of Health, Shiraz, Iran.
FAU - Dianatinasab, Mostafa
AU  - Dianatinasab M
AUID- ORCID: 0000-0002-0185-5807
AD  - Shiraz HIV/AIDS Research Center, Institute of Health, Shiraz University of 
      Medical Sciences, Shiraz, Iran.
AD  - Department of Epidemiology, Student Research Committee, Shiraz University of 
      Medical Sciences School of Health, Shiraz, Iran. fararooei@gmail.com.
LA  - eng
PT  - Journal Article
DEP - 20170518
PL  - Korea (South)
TA  - Diabetes Metab J
JT  - Diabetes & metabolism journal
JID - 101556588
CIN - Diabetes Metab J. 2017 Aug;41(4):322-323. PMID: 28868830
EIN - Diabetes Metab J. 2017 Oct;41(5):422. PMID: 29086542
PMC - PMC5489501
OTO - NOTNLM
OT  - Diabetes mellitus, type 2
OT  - Exercise
OT  - Glucose
OT  - Insulin resistance
OT  - Omentin-1
OT  - Overweight women
COIS- No potential conflict of interest relevant to this article was reported.
EDAT- 2017/05/26 06:00
MHDA- 2017/05/26 06:01
PMCR- 2017/06/01
CRDT- 2017/05/25 06:00
PHST- 2016/05/29 00:00 [received]
PHST- 2017/01/09 00:00 [accepted]
PHST- 2017/05/26 06:00 [pubmed]
PHST- 2017/05/26 06:01 [medline]
PHST- 2017/05/25 06:00 [entrez]
PHST- 2017/06/01 00:00 [pmc-release]
AID - 41.e8 [pii]
AID - 10.4093/dmj.2017.41.3.205 [doi]
PST - ppublish
SO  - Diabetes Metab J. 2017 Jun;41(3):205-212. doi: 10.4093/dmj.2017.41.3.205. Epub 
      2017 May 18.